Our findings demonstrate that TQ upregulates miR-199a-3p, leading to suppression of COX-2 expression and PGE2 production, together with inhibition of MAPK and NF-κB signaling in A549 and SHP-77 lung cancer cells. The gene discussed is NFKB1; the disease is lung carcinoma.